Literature DB >> 15529733

AANA Journal course: Update for nurse anesthetists--Part 4--preoperative cardiac evaluation.

Bob Halliburton1, Donald Bell, John Preston.   

Abstract

This AANA Journal course discusses the American College of Cardiology (ACC) and American Heart Association (AHA) guideline on perioperative cardiovascular evaluation for noncardiac surgery. The intent of the ACC/AHA guideline is to assist clinicians in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, and prevention of cardiac diseases. Optimizing the anesthetic management of the cardiac patient undergoing noncardiac surgery is becoming increasingly important: as the percentage of Americans older than 65 years continues to grow, so does the prevalence of cardiac disease in this population. Simply accepting a preoperative cardiology clearance for the cardiac patient undergoing noncardiac surgery provides little information that can be used for risk assessment and management of anesthesia. While national practice patterns vary significantly, there is an important need to standardize cost-effective preoperative cardiac evaluation. By using evidence-based studies, the ACC/AHA guideline delineates methods to objectively categorize cardiovascular risk and use data from the cardiology consultation to refine anesthetic management. Use of the guideline can lead to more efficient evaluation of the noncardiac patient with cardiac disease, which can decrease morbidity, mortality, and cost.

Entities:  

Mesh:

Year:  2004        PMID: 15529733

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  1 in total

Review 1.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Authors:  P J Devereaux; Lee Goldman; Deborah J Cook; Ken Gilbert; Kate Leslie; Gordon H Guyatt
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.